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Intestinal microbial flora plays critical role in maintenance of health. Probiotic organisms
have been recognized as an essential therapeutic component in the treatment of intestinal
dysbiosis. Current research suggests their health benefits extends beyond intestinal dis-
orders. The neuroactive molecules produced by the gut microbiota has been found to
modulate neural signals which affect neurological and psychiatric parameters like sleep,
appetite, mood and cognition. Use of these novel probiotics opens up the possibility of
restructuring of intestinal microbiota for effective management of various psychiatric
disorders.There is compelling evidence that most organic human dis-
eases also have psychiatric component [1]. This is especially
common in gastro-intestinal disorders such as inflammatory
bowel disease. Altered intestinalmicrobiota, i.e., dysbiosis has
been found to be strongly associated with these conditions [2].
In the light of research on human microbiome, it is now
possible to explain the significance of gut microbial consortia
inmental health. Among numerous commensal gutmicrobes,
Lactobacillus, Bifidobacterium, and Saccharomyces exert benefi-
cial health effects by restoring the balance of gut flora. These
beneficial bacteria, traditionally known as probiotics, have
been employed to treat intestinal dysbiosis associated with
prolonged antibiotic use, chemotherapy, Clostridium difficile
infection, and traveler's diarrhea. Interestingly, some of the
intestinal microbes, i.e., Lactobacillus acidophilus, Bifidobacte-
rium infantis, Bifidobacterium longum, Candida, and Streptococcusicrobiology, Mahatma G
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s/by-nc-nd/4.0/).have been found to produce psychotropic effects either by
secreting neurotransmitter molecules (e.g. gamma-
aminobutyric acid, glycine, serotonin, and catecholamines)
or by regulating endocannabinoid receptor expression [3]. The
term “psychobiotic” has been introduced to designate this
novel class of probiotics, which has wider applications in
psychiatric practice [4].
Enteric nervous system and vagus nerve connect intestine
with central nervous system. Microbe-derived neurotrans-
mitters or neuroactive molecules from enterocytes under
control of gut microbes influence the neural signaling of this
gutebrain axis [2]. The proinflammatory, anti-inflammatory,
and serotonergic signals are imperative for modulating sleep,
appetite, mood, and cognition [5]. Experimentally, mice with
altered intestinal flora (induced by vancomycin) and germ-free
mice (devoid of gut flora) displayed features of anxiety,andhi Medical College and Research Institute, Pondy-Cuddalore
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reversible on restoration of eubiosis by fecal transplant [2]. In
addition, the fecal transplant was found to reassign the per-
sonality of the donor mice to germ-free recipient animal.
Although psychobiotics have demonstrated encouraging re-
sults in animal model, the research data on human are inad-
equate. Reduction in anxiety, depression, and gut
inflammation was reported in patients on probiotics [5].
Given the high-cost and sophisticated techniques impera-
tive for drug designing, there is a lesser prospect of developing
novel synthetic molecules for therapy on continuous basis.
Moreover, prolonged use of traditional psychotropic drugs
often results in serious adverse effects. In contrast, psycho-
biotics are well-adapted to intestinal environment and natu-
rally modulate gutebrain axis, reducing the chance of adverse
reactions [4]. Wide spectrum of mental illnesses varying from
anxiety, autism, disorders of mood, behavior, and cognition
could be treated effectively [2]. Currently, there is immense
interest in studying the ancestral microbiota in primitive man
to restore the beneficial flora which is unaffected by modern-
ization. This approach may increase the possibility of identi-
fying unique psychobiotics with novel attributes for
therapeutic use. Since diet has immense influence on the gut
flora, it is likely that simple prescribing of particular diet may
be sufficient to promote the selective proliferation of natural or
therapeutically introduced psychobiotics, precluding the need
for repeated doses for maintenance therapy. Owing to their
inert and commensal nature, these organisms are less prone to
induce immune reaction. Thus, they are suitable candidates
for genetic engineering. This may open up infinite possibilitiesto design and restructure the gut microbiota predictably to
achieve society-wide control on mental illnesses in future.Financial support and sponsorship
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